Log in to save to my catalogue

A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resist...

A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resist...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3787876

A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer

About this item

Full title

A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer

Publisher

New York: Nature Publishing Group US

Journal title

Nature genetics, 2013-07, Vol.45 (7), p.747-755

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Pier Paolo Pandolfi and colleagues report that compound loss of
Pten
with
Zbtb7a
or
Trp53
leads to
de novo
resistance to androgen deprivation therapy in prostate cancer. Integrative analysis of mouse and human data in a co-clinical approach identified XIAP and SRD5A1 inhibitors as potential therapies for castration-resistant...

Alternative Titles

Full title

A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3787876

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3787876

Other Identifiers

ISSN

1061-4036

E-ISSN

1546-1718

DOI

10.1038/ng.2650

How to access this item